Your browser doesn't support javascript.
loading
Advanced Assay Monitoring APP-Carboxyl-Terminal Fragments as Markers of APP Processing in Alzheimer Disease Mouse Models.
García-Osta, Ana; Cuadrado-Tejedor, Mar.
Afiliação
  • García-Osta A; Cell and Molecular Neuropharmacology, Neurosciences Division, Centre for Applied Medical Research, CIMA, University of Navarra, Av. Pio XII 55, Pamplona, 31008, Spain, agosta@unav.es.
Methods Mol Biol ; 1303: 117-23, 2016.
Article em En | MEDLINE | ID: mdl-26235062
ABSTRACT
The 99-amino-acid-long APP-carboxy-terminal fragment, named C99, is a membrane-bound peptide generated from the amyloid precursor protein (APP) by ß-secretase cleavage and is the direct precursor of amyloid beta (Aß). Here we describe a method for the quantification of C99. The amount of C99 is an indicative value of the amyloid pathology in an Alzheimer's disease (AD) model, and could be used as a marker to study AD progression in comprehensive experiments, including screening for new compounds and repurposing of drugs to treat AD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Western Blotting / Precursor de Proteína beta-Amiloide / Doença de Alzheimer Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Western Blotting / Precursor de Proteína beta-Amiloide / Doença de Alzheimer Idioma: En Ano de publicação: 2016 Tipo de documento: Article